Pharmaceutical Profiles Limited

Crosstree was brought in to advise Pharmaceutical Profiles, on the other side of the Atlantic, in it's sale to Quotient Biosciences. Crosstree helped close the deal in 4 months in the heart of the financial downturn of 2008.

Please direct inquiries to:


Shane C. Senior, CFA

Managing Director

Crosstree Capital Partners, Inc.

(813) 774-4755

shane.senior@crosstreecapital.com

All securities activities for this transaction were conducted by our affiliate, Crosstree Capital Securities LLC, a registered SEC broker-dealer and member of FINRA and SIPC.